HIF inhibitor 32-134D eradicates murine hepatocellular carcinoma in combination with anti-PD1 therapy

Authors
Publication date
2 May 2022
Publisher
American Society for Clinical Investigation
Doi

    Abstract

    Abstract is not available.

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Crossref

      redirect
      oaiinfo:doi/10.1172%2Fjci156774
      Last time updated on 01/03/2025